Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
Solomon et al., Circulation, doi:10.1161/CIRCULATIONAHA.123.065190
https://c19early.org/solomon.html